European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older Adults
Obesity is increasingly prevalent among older adults and is a major contributor to cardiometabolic diseases, functional decline, frailty, and loss of independence. The intersection between population ageing and the obesity epidemic poses major public health and clinical challenges. This European Association for the Study of Obesity (EASO) position statement represents an update of the EASO guideline from 2012, and provides a comprehensive overview of the epidemiology, pathophysiology, clinical consequences, and management of obesity in adults aged ≥65 years. It summarizes current evidence and offers practical recommendations for diagnosis and treatment tailored to this age group. To guide clinicians and researchers through this updated framework, the position statement highlights four central concepts that underpin obesity assessment and management in later life: (1) obesity affects up to one-third of older adults globally, with prevalence varying by sex and geography; (2) ageing is associated with changes in body composition, hormonal milieu, and lifestyle factors (diet, physical inactivity, and polypharmacy) that favour fat accumulation and sarcopenic obesity; (3) body mass index alone is insufficient; assessment should include body composition analysis (including fat distribution and muscle mass), psychological status, and functional performance; (4) a multimodal approach is recommended, including moderate energy restriction with adequate protein intake, structured multicomponent exercise, behavioural support, and, where appropriate, obesity management medications and/or metabolic bariatric surgery. The focus should be on preserving muscle mass, functional capacity, and quality of life, rather than weight loss alone. Effective management of obesity in older adults should focus on individualized, multidisciplinary strategies that balance the benefits of weight reduction against the risks of sarcopenia, malnutrition, and loss of independence.
Authors
- Lorenzo M. Donini (ORCID: https://orcid.org/0000-0003-4692-4754)
- Silvia Migliaccio (ORCID: https://orcid.org/0000-0002-4563-6630)
- Dror Dicker (ORCID: https://orcid.org/0000-0001-8546-6245)
- Barbara McGowan (ORCID: https://orcid.org/0000-0003-2015-726X)
- Marianna Minnetti (ORCID: https://orcid.org/0000-0002-9091-2809)
- Emma Jane Boyland (ORCID: https://orcid.org/0000-0001-8384-4994)
- Volkan Yumuk (ORCID: https://orcid.org/0000-0001-6463-4916)
- Paolo Sbraccia (ORCID: https://orcid.org/0000-0001-9634-1501)
- Jennifer L. Baker (ORCID: https://orcid.org/0000-0002-9649-6615)
- Euan Woodward
- Gian Maria Busetto (ORCID: https://orcid.org/0000-0002-7291-0316)
- Olivia Di Vincenzo (ORCID: https://orcid.org/0000-0003-3152-3130)
- Ľubomíra Fábryová (ORCID: https://orcid.org/0000-0001-7756-9041)
- Eleonora Poggiogalle (ORCID: https://orcid.org/0000-0003-0862-5892)
- Rocco Barazzoni (ORCID: https://orcid.org/0000-0002-4049-2404)
- Andreea Ciudin (ORCID: https://orcid.org/0000-0001-5622-0203)
- Tryggvi Helgason
- Mette Svendsen (ORCID: https://orcid.org/0000-0002-0944-026X)
Institutions
- University of Rome Tor Vergata (IT)
- Hebron University (PS)
- Universitat Autònoma de Barcelona (ES)
- Reykjavík University (IS)
- Oslo University Hospital (NO)
- University of Padua (IT)
- University of Trieste (IT)
- University of Liverpool (GB)
- University of Oslo (NO)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Slovak Academy of Sciences (SK)
- Rabin Medical Center (IL)
- Frederiksberg Hospital (DK)
- Vall d'Hebron Institut de Recerca (ES)
- National University Hospital of Iceland (IS)
- Istanbul University-Cerrahpaşa (TR)
- Biomedical Research Center of the Slovak Academy of Sciences (SK)
- European Association for the Study of Obesity (GB)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Obesity Facts
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1159/000549751
- Citations
- 1
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- European Commission